Day 1 – CNS Venous Anatomy, the Glymphatic system and associated vascular diseases

 

At the end of this day, participants should be able to:

1. Recognize the normal and abnormal angioarchitecture of the CNS venous system and its variations.
2. Identify the role that the CNS veins and glymphatic system have in different vascular conditions/abnormalities such as dural arteriovenous fistulae (dAVFs), arteriovenous malformations (AVMs), venous and venolymphatic malformations and developmental venous anomalies.
3. Assess potential indications, risks and complications of endovascular treatment through the CNS venous system.

 

Karel terBrugge – Venous Anatomy: Supratentorial – Superficial and deep

Date:   Thur, Sept 26, 2024                                          Time:   0900 – 0930

After this session, the participants should be able to:

1. Describe the in utero and post-natal development of the intracranial supratentorial venous system.
2. Distinguish the anatomical and imaging characteristics of the supra tentorial deep and superficial venous system and its variants
3. Analyze the relationship between the imaging characteristics of variations of the intracranial supratentorial venous vascular anatomy and its clinical relevance.

Hidetsugu Maekawa – Venous Anatomy: The posterior fossa

Date:   Thur, Sept 26, 2024                                          Time:   0930 – 1000

After this session, the participants should be able to:

1. Describe the anatomy of the posterior fossa veins.
2. Recognize the clinical importance of posterior fossa venous anatomy.

 

Jesse Klostranec – Transmedullary Veins and Glymphatics

Date:   Thur, Sept 26, 2024                                          Time:   1000 – 1030

After this session, the participants should be able to:

1. Describe the glymphatic system within the central nervous system.
2. Discuss the role of the transmedullary veins in the glymphatic system.
3. Recognize potential neurological conditions/diseases that are related to abnormalities of the glymphatic system and the transmedullary veins.

 

Timo Krings – CASE DISCUSSIONS dAVF – transvenous Approaches: cavernous sinus

Date:   Thur, Sept 26, 2024                                          Time:   1100 – 1130

After this session, the participants should be able to:

1. Describe the venous anatomy surrounding the cavernous sinus.
2. Analyze different transvenous routes for treatment of cavernous sinus dAVFs.
3. Discuss the technical considerations and potential complications of transvenous embolization of cavernous sinus dAVFs.

 

Hidetsugu Maekawa – CASE DISCUSSIONS dAVF – transvenous Approaches: Cortical & Posterior fossa Veins

Date:   Thur, Sept 26, 2024                                          Time:   1130 – 1200

After this session, the participants should be able to:

1. Assess the neurovascular anatomy relevant to cortical and posterior fossa dAVFs.
2. Discuss the indications for transvenous embolization of cortical and posterior fossa dAVFs.
3. Discuss the technical considerations in transvenous embolization of cortical and posterior fossa dAVFs.

 

Vitor Pereira – CASE DISCUSSIONS AVMs – transvenous Approaches

Date:   Thur, Sept 26, 2024                                          Time:   1200 – 1230

After this session, the participants should be able to:

1. Describe the indications for transvenous approaches of brain AVMs.
2. Discuss the technical considerations for transvenous embolization of brain AVMs.
3. Recognize the potential complications for transvenous embolization of brain AVMs.

 

Waleed Brinjikji – Venous Anatomy – Approaches to the Spinal Epidural System

Date:   Thur, Sept 26, 2024                                          Time:   1330 – 1400

After this session, the participants should be able to:

1. Assess the neurovascular anatomy of the spinal epidural system.
2. Recognize the conditions/diseases associated with the spinal epidural system.
3. Discuss the technical considerations in approaching and treating conditions through the spinal epidural system.

 

Ronit Agid – Venous and venolymphatic Malformations

Date:   Thur, Sept 26, 2024                                          Time:   1400 – 1430

After this session, the participants should be able to:

1. Recognize the imaging characteristics and differentiate venous and venolymphatic malformations from other vascular diseases.
2. Discuss the natural history of venous and venolymphatic malformations.
3. Develop a treatment plan for venous and venolymphatic malformations.

 

Timo Krings – Developmental Venous Anomalies

Date:   Thur, Sept 26, 2024                                          Time:   1430 – 1500

After this session, the participants should be able to:

1. Recognize imaging characteristics of developmental venous anomalies.
2. Assess any clinical presentation with possible underlying pathologies associated with developmental venous anomalies.
3. Determine if any treatment is indicated or possible when associated with developmental venous anomalies.

 

Johanna Fifi – CASE DISCUSSIONS transvenous Pediatric Vascular Malformations

Date:   Thur, Sept 26, 2024                                          Time:   1530 – 1600

After this session, the participants should be able to:

1. Classify pediatric vascular malformations and compare the differences between pediatric and adult vascular malformations.
2. Discuss the indications of transvenous embolization in pediatric vascular malformations.
3. Discuss the technical considerations of transvenous embolization in pediatric vascular malformations.

 

Johanna Fifi – CASE DISCUSSION Venous Thrombosis

Date:   Thur, Sept 26, 2024                                          Time:   1600 – 1630

After this session, the participants should be able to:

1. Recognize clinical presentations and imaging characteristics of cerebral venous thrombosis.
2. Discuss various management options and the indications in cerebral venous thrombosis.
3. Discuss the technical considerations of endovascular treatment in cerebral venous thrombosis.

 

Emanuele Orru – CASE DISCUSSIONS CSF-Venous Fistulae

Date:   Thur, Sept 26, 2024                                          Time:   1630 – 1700

After this session, the participants should be able to:

1. Discuss the multiple modalities of treatment of CSF-Venous fistulae.
2. Describe the various endovascular approaches to different venous territories that can be used in treatment of CSF-Venous fistulae.

 

Day 2 – INR Symposium

 

At the end of this day, participants should be able to:

1. Discuss the indications, technical considerations and potential complications of using new devices in interventional neuroradiology.
2. Discuss and review recent and new clinical studies regarding stroke and antiaggregation treatment in various neurovascular diseases.
3. Apply knowledge of new imaging and endovascular techniques and devices for management of various neurological diseases.
4. Recognize the clinical manifestations, imaging features and treatment challenges of unusual or controversial neurovascular diseases, such as bridging vein dAVFs, matricidal, blister and perforator aneurysms.

 

Timo Krings – Miniballoons for Brain AVMs – Transvenous and Transarterial Routes

Date:   Fri, Sept 27, 2024                                         Time:   0800 – 0820

After this session, the participants should be able to:

1. Describe the indications for using miniballoons in brain AVMs in both the transarterial and transvenous routes.
2. Discuss the technical considerations for preparing and using miniballoons.
3. Recognize potential complications of using miniballoons in embolizations.

 

Fabio Settecase – Do we need Microcatheters for advancing Aspiration Catheters?

Date:   Fri, Sept 27, 2024                                         Time:   0820 – 0840

After this session, the participants should be able to:

1. Describe the challenges in successful use of aspiration catheters and strategies that can be used to overcome the challenges.
2. Analyze different types of microcatheters and how they can help in advancing aspiration catheters.

 

Will Guest – The non-stenotic vulnerable & symptomatic plaque: To treat or not to treat?

Date:   Fri, Sept 27, 2024                                         Time:   0830 – 0900

After this session, the participants should be able to:

1. Describe the imaging characteristics and clinical significance of non-stenotic vulnerable & symptomatic plaque.
2. Discuss the management options of non-stenotic vulnerable & symptomatic plaque.
3. Recognize the technical considerations and the potential complications of endovascular treatment of non-stenotic vulnerable & symptomatic plaque.

 

David Volders – Lecture Topic: Can we standardize Aspiration Techniques?

Date:   Fri, Sept 27, 2024                                         Time:   0840 – 0900

After this session, the participants should be able to:

1. Discuss different aspiration techniques and equipment that can be used.
2. Discuss the benefits and challenges of standardizing aspiration techniques.

 

 

Adnan Siddiqui – Single antiplatelet agent stent assisted coiling for ruptured aneurysms

Date:   Fri, Sept 27, 2024                                         Time:   0900 – 0930

After this session, the participants should be able to:

1. Discuss the need for antiplatelet agents after stent assisted coiling.
2. Recognize the potential risk for using antiplatelet agents in ruptured aneurysms.
3. Discuss the strategies and types of antiplatelet agents that can be used when stent assisted coiling is required for ruptured aneurysms.

 

Karen Chen – Fetal cerebrovascular Anomalies

Date:   Fri, Sept 27, 2024                                         Time:   1000 – 1030

After this session, the participants should be able to:

1. Recognize imaging characteristics of fetal cerebrovascular anomalies.
2. Discuss technical challenges and how to overcome them in fetal imaging.
3. Discuss management plan for detected fetal cerebrovascular anomalies.

 

Staffan Holmin – Vessel Exit Strategies

Date:   Fri, Sept 27, 2024                                         Time:   1030 – 1100

After this session, the participants should be able to:

1. Describe what organs are relevant to target with the Extroducer device.
2. Describe what type of payloads that could be delivered with the Extroducer system.
3. Discuss the potential of -omics analysis of small samples obtained via the endovascular route.

 

Adnan Siddiqui – Endovascular Neurooncology

Date:   Fri, Sept 27, 2024                                         Time:   1100 – 1130

After this session, the participants should be able to:

1. Discuss how endovascular treatment can be used in Neurooncology.
2. Discuss the benefits of newer modalities, particularly direct arterial infusion and how they work through the blood brain barrier.

 

Tomas Dobrocky – How to manage the calcific embolus

Date:   Fri, Sept 27, 2024                                         Time:   1110 – 1130

After this session, the participants should be able to:

1. Identify calcified emboli in acute ischemic stroke and differentiate it from ICAD.
2. Recognize the challenges associated with mechanical thrombectomy of calcified emboli.
3. Discuss how to adapt the thrombectomy technique according to specific clot features.

 

Ivan Radovanovic – Liquid Biopsies

Date:   Fri, Sept 27, 2024                                         Time:   1130 – 1200

After this session, the participants should be able to:

1. Describe the clinical applications of liquid biopsies in various clinical settings.
2. Discuss the technical considerations for liquid biopsies in the brain and spine.

 

Ronit Agid – Venous hypertensive Manifestations in dAVF

Date:   Fri, Sept 27, 2024                                         Time:   1300 – 1330

After this session, the participants should be able to:

1. Discuss clinical presentation and imaging characteristics of venous hypertension associated with dAVFs.
2. Determine the target for management of the venous hypertension in dAVFs.

 

Eef Hendriks – Direct CCFs

Date:   Fri, Sept 27, 2024                                         Time:   1330 – 1400

After this session, the participants should be able to:

1. Describe clinical findings and imaging characteristics of direct Carotid-Cavernous Fistulae (CCFs).
2. Discuss management strategies and technical considerations for endovascular treatment of direct CCFs.
3. Recognize potential complications and their management of direct CCF treatment.

 

Sean O’Reilly – Spinal dAVF’s an update

Date:   Fri, Sept 27, 2024                                         Time:   1400 – 1430

After this session, the participants should be able to:

1. Recognize variant form of spinal dAVFs.
2. Describe the unique presentation of spinal dAVFs as compared to intracranial dAVFs.
3. Analyze the latest evidence regarding clinical and imaging predictors of patient outcomes following treatment for spinal dAVFs.

 

Tze Phei Kee – Bridging Vein dAVF

Date:   Fri, Sept 27, 2024                                         Time:   1430 – 1500

After this session, the participants should be able to:

1. Identify and differentiate parasagittal vs SSS DAVFs on imaging.
2. Describe the pathophysiology of bridging vein DAVF formation.
3. Debate different endovascular treatment strategies for these two entities.

 

Uzair Ahmed – CASES: Matricidal Aneurysms

Date:   Fri, Sept 27, 2024                                         Time:   1530 – 1600

After this session, the participants should be able to:

1. Identify imaging characteristics and clinical significance of Matricidal aneurysms.
2. Discuss treatment strategies and technical consideration of endovascular treatment for Matricidal aneurysms.
3. Recognize potential complications of Matricidal aneurysm treatment.

 

Daniel Roy – CASES: Blister & Perforator Aneurysms

Date:   Fri, Sept 27, 2024                                         Time:   1600 – 1630

After this session, the participants should be able to:

1. Identify imaging characteristics and clinical significance of Blister and Perforator aneurysms.
2. Discuss treatment strategies and technical consideration of endovascular treatment for Blister and Perforator aneurysms.
3. Recognize potential complications of Blister and Perforator aneurysm treatment.

 

Antti Lindgren – CASES: Unexpected findings during and after Aneurysm Treatment

Date:   Fri, Sept 27, 2024                                         Time:   1630 – 1700

After this session, the participants should be able to:

1. Identify different endosaccular aneurysm treatment devices
2. Recognize possible issues with endosaccular devices
3. Recognize anatomical features of aneurysms that associate with unexpected outcomes during and after treatment with endosaccular devices

 

Day 3 – INR Symposium

 

At the end of this day, participants should be able to:

1. Discuss recent advances and studies in treatment of neurovascular diseases.
2. Examine and choose treatment strategies for patients with stroke.
3. Analyze and discuss the challenges of women in Interventional Neuroradiology.

 

Federico Carpani – Blood Pressure Management before, during and after EVT

Date:   Sat, Sept 28, 2024                                        Time:   0800 – 0830

After this session, the participants should be able to:

1. Describe the current knowledge and strategies for Blood Pressure (BP) management around EVT
2. Discuss how we need to approach BP management in the future.

 

Sachin Pandey – Carotid Web

Date:   Sat, Sept 28, 2024                                        Time:   0900 – 0930

After this session, the participants should be able to:

1. Determine the indications for using a Carotid Web.
2. Discuss the technical considerations for deploying the Carotid Web.
3. Recognize the potential complications of the Carotid Web and how to manage them.

 

 

Joanna Schaafsma – Medical Decision-making for Unruptured Intracranial Aneurysms

Date:   Sat, Sept 28, 2024                                        Time:   0930 – 1000

After this session, the participants should be able to:

1. Recognize the pearls and pitfalls of prediction scores for rupture risk and treatment risk.
2. Discuss the concept of decision-conflict for unruptured intracranial aneurysms.
3. Apply shared-decision making strategies for unruptured intracranial aneurysms.

 

Alexandre Yves Poppe – Antiaggregation Management in Stroke – Tandem Lesions & ICAD

Date:   Sat, Sept 28, 2024                                        Time:   1030 – 1050

After this session, the participants should be able to:

1. Discuss the current antiaggregation management options in Stroke.
2. Determine the management strategies of antiaggregation management in Tandem Lesions & ICAD and how it differs from other diseases/conditions.
3. Analyze the recent and future studies of antiaggregation management in Tandem Lesions & ICAD.

 

Hugo Andrade – Moya Moya Disease

Date:   Sat, Sept 28, 2024                                        Time:   1050 – 1110

After this session, the participants should be able to:

1. Describe the clinical presentation and characteristic imaging findings in Moya Moya disease.
2. Discuss the current management of Moya Moya disease.

 

Andrew Demchuk – Large Core Stroke;  Distal Occlusions, Low NIHSS – what do current studies say?

Date:   Sat, Sept 28, 2024                                        Time:   1130 – 1150

After this session, the participants should be able to:

1. Analyze the current studies with large core stroke, distal occlusions and low NIHSS and their results.
2. Discuss how to apply the results of the study to management of the corresponding stroke type in clinical practice.
3. Describe possible future studies in the field.

 

Sirintara Pongpech – KTB LECTURESHIP – Women in Neurointervention – The Asian Perspective

Date:   Sat, Sept 28, 2024                                        Time:   1300 – 1330

After this session, the participants should be able to:

1. Determine challenges that women face when practicing neurointervention.
2. Discuss about women’s status in INR practice in Asia and other parts of the world.
3. Determine strategies that can encourage women to practice neurointervention.

 

David Volders, Jesse Klostranec, Uzair Ahmed, Danielo Diestro – Decision Making in Acute Stroke:  Tough Cases from Halifax, Montreal, Saskatoon and St. Mikes, Toronto.

Date:   Sat, Sept 28, 2024                                        Time:   1330 – 1500

After these sessions, the participants should be able to:

1. Recognize variations in acute stroke presentations.
2. Practice clinical decision making in acute stroke situations from the example cases.
3. Explain the current best practices in acute stroke care.